Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model
Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model
复制标题
白细胞介素 12 基因转移和白细胞介素 18 全身给药在小鼠膀胱癌模型中的协同抗肿瘤作用
DOI:
--
复制
发表时间:
1999
期刊:
影响因子:
--
通讯作者:
S. Kamidono
中科院分区:
文献类型:
--
作者:
K. Yamanaka;I. Hara;H. Nagai;H. Miyake;K. Gohji;M. Micallef;M. Kurimoto;S. Arakawa;S. Kamidono
Abstract We introduced the interleukin-12 (IL-12) gene into the mouse bladder cancer cell line (MBT2) to establish sublines that secrete bioactive IL-12. IL-12-secreting MBT2 (MBT2/IL-12) sublines were completely rejected when subcutaneously implanted into immunocompetent syngeneic C3H mice. Although this antitumor effect did not change when IL-12-secreting cells were injected into immunodeficient mice whose CD8+ T or CD4+ T cells had been depleted by the corresponding antibody, it was abrogated when natural killer cells were depleted by anti-asialoGM1 antibody. In addition, when parental MBT2 cells mixed with MBT2/IL-12 cells were subcutaneously injected into mice, admixed MBT2/IL-12 inhibited the growth of the parental tumor. Furthermore, this antitumor effect was enhanced by systemic IL-18 administration. This synergism was abrogated when the mice were treated with interferon-γ-neutralizing antibody in vivo. In conclusion, local secretion of IL-12 led to effective antitumor activity that was enhanced by systemic administration of IL-18. Interferon-γ plays an important role in the synergism of IL-12 gene transduction and systemic administration of IL-18.
影响因子:
5.3
作者:
Okayama,H;Berg,P
通讯作者:
Berg,P
DOI:
--
发表时间:
1995
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Tahara,H;Zitvogel,L;Storkus,WJ;Zeh3rd,HJ;McKinney,TG;Schreiber,RD;Gubler,U;Robbins,PD;Lotze,MT
通讯作者:
Lotze,MT